Cincinnati, Ohio — According to state and local economic development sources Medpace plans to invest $150,000,000.00 to build out 250,000 square feet of new space in Cincinnati. The company plans to occupy the new space at 5375 Medpace Way in Cincinnati, on or about December 1, 2024. According to the company website Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpaces mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,700 people across 41 countries.

To learn more about Medpace, visit http://www.medpace.com/

Company Contact:
Jesse Geiger, President
https://www.linkedin.com/in/jesse-geiger-10b27622/
513-579-9911

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.